ESEF — Europäische Jahresabschlüsse (iXBRL) fact · point in time
DECHRA PHARMACEUTICALS LIMITED: cash_and_equivalents
One fact, its scope and the complete path back to the official record.
Reported value
118.400M{"amount": 118400000.0, "concept": "ifrs-full:CashAndCashEquivalents"}- Metric
- cash_and_equivalents
- Period
- as of 2021-06-30
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:213800J4UVB5OWG8VX82:2023-06-30Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T00:25:17.069978+02:00
Raw response SHA-256
5a3e6d746432fb6427082e8eae673120…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.